Gastrointestinal selective capacity of doripenem, meropenem, and imipenem for carbapenem-resistant gram-negative bacilli in treated patients with pneumonia.

@article{Apisarnthanarak2011GastrointestinalSC,
  title={Gastrointestinal selective capacity of doripenem, meropenem, and imipenem for carbapenem-resistant gram-negative bacilli in treated patients with pneumonia.},
  author={Anucha Apisarnthanarak and Pattarachai Kiratisin and Piyaporn Apisarnthanarak and Linda M Mundy},
  journal={Infection control and hospital epidemiology},
  year={2011},
  volume={32 4},
  pages={410-1}
}
To the Editor—Multidrug-resistant gram-negative bacilli (GNB) have emerged as major infectious threats and therapeutic challenges for physicians worldwide.' Infections with these multidrug-resistant pathogens have been associated with poor patient outcomes. Data on the emergence of carbapenem-resistant (CR) GNB in gastrointestinal flora and the selective… CONTINUE READING